TAG:
lab tests
Understanding the Future Of Laboratory Medicine
By Robert Michel | From the Volume XXIII No. 4 – March 21, 2016 Issue
CEO SUMMARY: Healthcare’s transformation is now far enough along that most clinical labs and pathology groups are either feeling the financial pain or are excitedly developing ways to deliver more value from lab testing services. On April 26-27, at the 21st annual …
Payers Using Two Approaches To Price Molecular, Genetic Tests
By Joseph Burns | From the Volume XXIII No. 3 – February 29, 2016 Issue
PRIVATE PAYERS AND MEDICARE contractors are taking divergent approaches to establishing coverage policies and setting prices for molecular and genetic tests. That’s what Kuo Bianchini Tong, MS, CEO of Quorum Consulting Inc., sees happening. “One approach seeks to recognize the c…
Florida bill to restrict BeaconLBS advances in state Senate
By Mary Van Doren | From the Volume XXIII, No. 2 – February 8, 2016 Issue
THE DARK REPORT is first to report on the latest development as part of its ongoing coverage of how Florida physicians are reacting to the implementation of the UnitedHealthCare laboratory be…
Newsmaker Interview: Matthew Hawkins
By Joseph Burns | From the Volume XXIII, No. 2 – February 8, 2016 Issue
CEO SUMMARY: By now, most pathologists and clinical laboratory administrators recognize that effective use of information technology will be a critical success factor as healthcare systems transform to do population health management and to use “big data” with value-based payment mode…
Healthcare’s Ongoing Struggle: Patients or Profits?
By R. Lewis Dark | From the Volume XXIII, No. 2 – February 8, 2016 Issue
ALL THE MISPLACED INCENTIVES OF A HEALTHCARE SYSTEM that uses fee-for-service to reimburse providers continue. The diverse spread of lab industry business intelligence presented in this issue of THE DARK REPORT vividly demonstrates that there continues to be a “best” and a “worst” in provider…
Florida AG Opposes Bill Over Customary Charges
By Joseph Burns | From the Volume XXIII, No. 2 – February 8, 2016 Issue
CEO SUMMARY: It was a surprise to the Florida Attorney General that a bill had surfaced in the Florida Legislature to amend the existing state law’s definition of usual and customary pricing to the Medicaid program. The bill would even make that change in definition retroactive. If this…
Phlebotomy Contributes To Drop in Sepsis Mortality
By Joseph Burns | From the Volume XXIII, No. 2 – February 8, 2016 Issue
CEO SUMMARY: When Intermountain Healthcare began a quality improvement program to address sepsis, its sepsis mortality rate was 20.2%, among the lowest in the nation. By 2007, all 15 of its hospitals had deployed this program. A breakthrough came in recent years, when a phlebotomist was a…
Lab Benefit Management Bill Advances in FL Senate
By Joseph Burns | From the Volume XXIII, No. 2 – February 8, 2016 Issue
CEO SUMMARY: To date, a bill to restrict how health insurers use lab benefit management systems such as UnitedHealthcare’s BeaconLBS, has been favorably received in the Florida Senate. But the bill may face opposition when presented to the Senate’s Appropriations Committee. In a repor…
Direct Access Testing Wars Are Heating Up
By Mary Van Doren | From the Volume XXIII, No. 1 – January 19, 2016 Issue
CEO SUMMARY: In Phoenix, where Theranos already operates patient service centers in about 40 Walgreens pharmacies, Sonora Quest Diagnostics has an agreement with Safeway to provide clinical laboratory testing service…
After Theranos-Safeway Split, Grocer Picks Sonora Quest Laboratories
By Joseph Burns | From the Volume XXIII, No. 1 – January 19, 2016 Issue
IT’S RARE TO FIND ONE COMPANY STEP IN after another fails to execute a business strategy successfully. But that happened when Sonora Quest Laboratories in Scottsdale, Arizona, moved to fill the void created when Theranos Inc. did not fulfill an agreement to open pa…
CURRENT ISSUE

Volume XXXII, No. 7 – May 12, 2025
Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized